Logo image
Impact of metagenomic next-generation sequencing on clinical decision-making at an academic medical center, a retrospective study, Iowa, 2020–2022
Journal article   Open access   Peer reviewed

Impact of metagenomic next-generation sequencing on clinical decision-making at an academic medical center, a retrospective study, Iowa, 2020–2022

Michael Olthoff, Takaaki Kobayashi, Meredith Parsons, Bradley Ford, Kunatum Prasidthrathsint, Lemuel Non, Jorge Salinas, Daniel Diekema and Dilek Ince
Antimicrobial stewardship & healthcare epidemiology : ASHE, Vol.4(1), e39
03/27/2024
DOI: 10.1017/ash.2024.31
PMCID: PMC10983051
PMID: 38562514
url
https://doi.org/10.1017/ash.2024.31View
Published (Version of record) Open Access

Abstract

We assessed the impact of metagenomic next-generation sequencing (mNGS) on patient care using previously established criteria. Among 37 patients receiving mNGS testing, 16% showed results that had a positive clinical impact. While mNGS results may offer valuable supplementary information, results should be interpreted within the broader clinical context and evaluation.
Epstein-Barr Virus Infectious Diseases Tuberculosis Human papillomavirus UIOWA OA Agreement

Details

Metrics

12 Record Views
Logo image